Methyclothiazide

CHEMBL1577 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
360.2 g/mol
LogP
1.4
Phase
4

A thiazide diuretic used to treat high blood pressure and fluid retention (edema) caused by heart failure, kidney disease, or liver disease. It works by increasing urine output to reduce fluid and lower blood pressure.

Peso Molecular

360,2000 g/mol

LogP

1,40

TPSA

126,00 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Mecanismo de Ação

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O

InChI

InChI=1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16)

Molecular Formula

C9H11Cl2N3O4S2

HBD / HBA

2 / 7

Ligações Rotacionáveis

2

Átomos Pesados

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A thiazide diuretic used to treat high blood pressure and fluid retention (edema) caused by heart failure, kidney disease, or liver disease. It works by increasing urine output to reduce fluid and lower blood pressure.

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Yes, Methyclothiazide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1577. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4121. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.